Listed by the USPTO as ULLMAN, AARON RAFANAN
Tech Center 1600 • Art Units: 1628
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18501323 | COMBINATIONS FOR TREATMENT OF CANCERS RESISTANT TO EGFR-TARGETED THERAPIES | Final Rejection | Ohio State Innovation Foundation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your StrategyAaron Rafanan Ullman examines applications in Art Unit 1628 in Tech Center 1600 (Biotechnology & Pharmaceuticals).